Peak6 Investments LLC Regeneron Pharmaceuticals, Inc. Call Options Transaction History

Peak6 Investments LLC

$43.5 Billion
Q3 2024

Call Options

25 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 13, 2024	SELL	$1024.09 - $1201.76 $1.74 Million - $2.04 Million	-1,700 Reduced 30.91%	3,800 $3.99 Million
Q2 2024 Aug 13, 2024	SELL	$883.2 - $1071.19 $9.54 Million - $11.6 Million	-10,800 Reduced 66.26%	5,500 $5.78 Million
Q1 2024 May 14, 2024	BUY	$902.69 - $993.35 $1.35 Million - $1.49 Million	1,500 Added 10.14%	16,300 $15.7 Million
Q4 2023 Feb 13, 2024	SELL	$775.18 - $881.7 $9.07 Million - $10.3 Million	-11,700 Reduced 44.15%	14,800 $13 Million
Q3 2023 Nov 13, 2023	SELL	$692.45 - $844.37 $2.22 Million - $2.7 Million	-3,200 Reduced 10.77%	26,500 $21.8 Million
Q2 2023 Aug 11, 2023	BUY	$700.03 - $830.35 $6.02 Million - $7.14 Million	8,600 Added 40.76%	29,700 $21.3 Million
Q1 2023 May 12, 2023	BUY	$680.49 - $826.97 $6.33 Million - $7.69 Million	9,300 Added 78.81%	21,100 $17.3 Million
Q4 2022 Feb 10, 2023	SELL	$705.89 - $766.39 $19.3 Million - $20.9 Million	-27,300 Reduced 69.82%	11,800 $8.51 Million
Q3 2022 Nov 14, 2022	SELL	$573.97 - $724.32 $17.5 Million - $22.1 Million	-30,500 Reduced 43.82%	39,100 $26.9 Million
Q2 2022 Aug 12, 2022	SELL	$548.35 - $738.84 $438,680 - $591,072	-800 Reduced 1.14%	69,600 $41.1 Million
Q1 2022 May 13, 2022	SELL	$595.12 - $698.43 $6.78 Million - $7.96 Million	-11,400 Reduced 13.94%	70,400 $49.2 Million
Q4 2021 Feb 11, 2022	BUY	$543.48 - $670.97 $13.8 Million - $17 Million	25,300 Added 44.78%	81,800 $51.7 Million
Q3 2021 Nov 12, 2021	SELL	$574.03 - $680.96 $3.54 Million - $4.2 Million	-6,162 Reduced 9.83%	56,500 $34.2 Million
Q2 2021 Aug 13, 2021	BUY	$472.8 - $558.54 $22.5 Million - $26.6 Million	47,662 Added 317.75%	62,662 $38.4 Million
Q1 2021 May 14, 2021	SELL	$446.73 - $548.2 $37.6 Million - $46.1 Million	-84,100 Reduced 84.86%	15,000 $7.1 Million
Q4 2020 Feb 12, 2021	BUY	$478.3 - $607.98 $13.2 Million - $16.8 Million	27,600 Added 38.6%	99,100 $47.9 Million
Q3 2020 Nov 13, 2020	SELL	$544.75 - $658.21 $56.9 Million - $68.8 Million	-104,500 Reduced 59.38%	71,500 $40 Million
Q2 2020 Aug 14, 2020	SELL	$493.32 - $643.92 $2.81 Million - $3.67 Million	-5,700 Reduced 3.14%	176,000 $110 Million
Q1 2020 May 14, 2020	BUY	$336.18 - $494.43 $49.3 Million - $72.4 Million	146,500 Added 416.19%	181,700 $88.7 Million
Q4 2019 Feb 13, 2020	BUY	$274.13 - $376.51 $4.25 Million - $5.84 Million	15,500 Added 78.68%	35,200 $13.2 Million
Q3 2019 Nov 08, 2019	SELL	$273.46 - $318.39 $574,266 - $668,619	-2,100 Reduced 9.63%	19,700 $5.47 Million
Q2 2019 Aug 14, 2019	SELL	$299.6 - $414.82 $808,920 - $1.12 Million	-2,700 Reduced 11.02%	21,800 $6.82 Million
Q1 2019 May 15, 2019	BUY	$372.08 - $439.57 $6.77 Million - $8 Million	18,200 Added 288.89%	24,500 $10.1 Million
Q4 2018 Feb 13, 2019	SELL	$335.82 - $403.04 $18.5 Million - $22.2 Million	-55,000 Reduced 89.72%	6,300 $2.35 Million
Q3 2018 Nov 13, 2018	BUY	$351.14 - $408.51 $21.5 Million - $25 Million	61,300 New	61,300 $24.8 Million

Others Institutions Holding REGN

# of Institutions

1,534

Shares Held

83.6M

Call Options Held

1.22M

Put Options Held

1.51M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $76.4B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Peak6 Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Peak6 Investments LLC with notifications on news.

Account